| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 16,744 | 37,270 | 30,871 |
|
Selling General and Administrative | 12,901 | 13,344 | 6,631 |
|
Non Recurring | 2,158 |
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(31,804)
|
(50,614)
|
(37,503)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 68 | 162 | 243 |
|
Earnings Before Interest And Taxes | (31,736) | (50,452) | (37,260) |
|
Interest Expense |
-
|
-
| 70 |
|
Income Before Tax | (31,736) | (50,452) | (37,330) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (31,736) | (50,452) | (37,330) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(31,736)
|
(50,452)
|
(37,330)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(31,736)
|
(50,452)
|
(37,330)
|
|